Rchr
J-GLOBAL ID:201501009790797259   Update date: Nov. 22, 2024

Matsubara Daisuke

マツバラ ダイスケ | Matsubara Daisuke
Affiliation and department:
Homepage URL  (1): https://kaken.nii.ac.jp/d/r/80415554.ja.html
Research field  (2): Human pathology ,  Tumor diagnostics and therapeutics
Research keywords  (26): 肺腺癌 ,  肺癌 ,  MET ,  KRAS ,  CK7 ,  BRG1 ,  MUC1 ,  EGFR ,  EMT ,  TTF-1 ,  EMT ,  BRM ,  Lung adenocarcinoma ,  クロマチンリモデリング ,  MET inhibitor ,  細胞接着分子 ,  非小細胞肺癌 ,  CADM1 ,  浸潤 ,  糖鎖修飾 ,  miRNA ,  転移 ,  がんの個性診断 ,  小細胞肺癌 ,  分子標的薬 ,  分子標的
Research theme for competitive and other funds  (18):
  • 2022 - 2025 Analysis of the mechanisms of metastasis of lung adenocarcinoma by low-attachment spheroid culture
  • 2022 - 2025 Elucidation of mechanisms of carcinogenesis, metastasis, and metabolism based on histological characteristics of HNF4alpha-positive lung adenocarcinoma
  • 2020 - 2024 Development of novel diagnostic and therapeutic approaches to cancer by analyzing specific features of the immunoglobulin superfamily of molecules.
  • 2020 - 2023 悪性中皮腫におけるオキシトシン受容体を標的とした新規治療法の開発
  • 2018 - 2021 Integrated regulatory mechanism that govern differentiation and survival of driver-mutation-independent lung adenocarcinoma
Show all
Papers (91):
  • Masayo Hasegawa, Yusuke Amano, Atsushi Kihara, Daisuke Matsubara, Noriyoshi Fukushima, Hideyuki Takahashi, Kazuaki Chikamatsu, Hiroshi Nishino, Yoshiyuki Mori, Naohiro Yoshida, et al. Guanylate binding protein 5 is an immune-related biomarker of oral squamous cell carcinoma: A retrospective prognostic study with bioinformatic analysis. Cancer medicine. 2024. 13. 13. e7431
  • Satoshi Fukuda, Naoyuki Hasegawa, Kensaku Mori, Hitomi Kawai, Yusuke Niisato, Masato Endo, Emiko Seo, Noriaki Sakamoto, Daisuke Matsubara, Kiichiro Tsuchiya. Shrinkage of Enlarged Hepatic Nodules by an Embolizing Congenital Extrahepatic Portosystemic Shunt. Internal medicine (Tokyo, Japan). 2024. 63. 9. 1237-1242
  • Aya Shiba-Ishii, Takayuki Isagawa, Toshihiro Shiozawa, Naoko Mato, Tomoki Nakagawa, Yurika Takada, Kanon Hirai, Jeongmin Hong, Anri Saitoh, Norihiko Takeda, et al. Novel therapeutic strategies targeting bypass pathways and mitochondrial dysfunction to combat resistance to RET inhibitors in NSCLC. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 2024. 167249-167249
  • Hitomi Kawai, Tamaki Miura, Natsumi Kawamatsu, Tomoki Nakagawa, Aya Ishii Shiba, Taichiro Yoshimoto, Yusuke Amano, Atsushi Kihara, Yuji Sakuma, Kazutaka Fujita, et al. Expression patterns of HNF4α, TTF-1, and SMARCA4 in lung adenocarcinomas: impacts on clinicopathological and genetic features. Virchows Archiv. 2024
  • Yusuke Amano, Daisuke Matsubara, Atsushi Kihara, Taichiro Yoshimoto, Noriyoshi Fukushima, Hiroshi Nishino, Yoshiyuki Mori, Toshiro Niki. The significance of Hippo pathway protein expression in oral squamous cell carcinoma. Frontiers in medicine. 2024. 11. 1247625-1247625
more...
MISC (47):
  • 伊東剛, 舩城桐子, 種井善一, 仁木和郎, 松原大祐, 村上善則. CADM1 enhances the growth and metastasis of small-cell lung cancer. 日本がん転移学会学術集会・総会プログラム抄録集. 2021. 30th
  • Takehiro Tsuchiya, Hideki Kuwano, Takeshi Ito, Masayoshi Nagata, Taketo Kawai, Yumi Tsuboi, Daisuke Matsubara, Isami Okamoto, Kenji Tamura, Jun Nakajima, et al. Novel mechanisms of EGFR-TKI resistance and clonal evolution of lung adenocarcinoma by overexpression of a cell adhesion molecule, CADM1. CANCER RESEARCH. 2020. 80. 21
  • 鎌谷高志, 平田真, 植田幸嗣, 片山琴絵, 山口類, 山口類, 松原大祐, 藤田征志, 高澤豊, 山下享子, et al. Immunological analysis of the tumor microenvironment for myxoid liposarcoma. 日本癌学会学術総会抄録集(Web). 2020. 79th
  • 伊東剛, 舩城桐子, 種井善一, 松原大祐, 松原大祐, 村上善則. CADM1 enhances the growth and metastasis of small-cell lung cancer. 日本がん転移学会学術集会・総会プログラム抄録集. 2020. 29th
  • 内山 拓, 永山 理恵, 柴原 純二, 福嶋 敬宜, 松原 大祐, 川合 謙介, 五味 玲. DNTの病理学的特徴を持つ、播種した側頭葉腫瘍の1例. Brain Tumor Pathology. 2019. 36. Suppl. 124-124
more...
Books (13):
  • Minimally invasive adenocarcinoma of the lung
    WHO Classification of Tumours: Thoracic Tumours, 5th ed. 2021
  • Atypical adenomatous hyperplasia of the lung
    WHO Classification of Tumours: Thoracic Tumours, 5th ed. 2021
  • Invasive non-mucinous adenocarcinoma of the lung
    WHO Classification of Tumours: Thoracic Tumours, 5th ed. 2021
  • 肺癌 神経内分泌腫瘍
    病理と臨床 第39巻7号, 文光堂, pp.647-659 2021
  • 肺腫瘍の細胞分化に関わる転写因子と転写制御因子;その生物学的意義と病理診断における役割
    肺癌 第61巻第2号, 日本肺癌学会, pp.77-87, 2021-04 2021
more...
Lectures and oral presentations  (5):
  • Lung Cancer Pathology and Research
    (第112回 日本病理学会 2023)
  • What is YAP-positive HGNEC?
    (Spring meeting of ÖGPath/IAP Austria at TechGate Vienna 2023)
  • Pathology of Lung Cancer
    (2022)
  • Special Lecture: "Research Based on Lung Cancer Pathology Diagnosis
    (Lung Cancer Clinical Conference in Nagoya 2022)
  • Molecular and phenotypic diversity of lung adenocarcinomas
    (The 14th Nikko International Symposium 2017 Molecular Target Therapy and Diagnostics 2017)
Education (3):
  • 2000 - 2004 東京大学医学系研究科 人体病理学教室
  • 1996 - 2000 The University of Tokyo Faculty of Medicine School of Medicine
  • 1994 - 1996 The University of Tokyo
Professional career (1):
  • 医学博士 (東京大学)
Work history (9):
  • 2022/04 - 現在 筑波大学附属病院 病理診断 科長(病理部長)
  • 2022/04 - 現在 筑波大学附属病院 つくばヒト組織診断センター 部長
  • 2021/04 - 現在 University of Tsukuba Dept. of diagnostic pathology Professor and Chairman
  • 2021/04 - 2025/03 Jichi Medical University Div. of integrative pathology visiting professor
  • 2015/07 - 2021/03 The Institute of Medical Science, The University of Tokyo Visiting Associate Professor
Show all
Committee career (12):
  • 2023/09 - 現在 IASLC pathology committee member
  • 2023/01 - 現在 Pathology International Associate editor
  • 2023/01 - 現在 日本肺癌学会 学術委員会委員
  • 2022/04 - 現在 文光堂「病理と臨床」 編集アドバイザー
  • 2022/04 - 現在 日本肺癌学会関東支部会 病理アドバイザー
Show all
Awards (5):
  • 2018/11 - The excellent paper prize on Jichi Medical University
  • 2018/11 - The Japanese Society of Pathology Pathology Research Award (type A)
  • 2014/11 - The International Academy of Pathology (IAP) Young Investigator Award
  • 2010/04 - The Japanese Society of Pathology Young Investigator Award
  • 2009/11 - The Japan Lung Cancer Society Poster Award
Association Membership(s) (4):
THE JAPANESE SOCIETY OF CLINICAL CYTOLOGY ,  THE JAPAN LUNG CANCER SOCIETY ,  THE JAPANESE SOCIETY OF PATHOLOGY ,  THE JAPANESE CANCER ASSOCIATION
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page